Marc C. Patterson, M.D., is the US Chief Medical Officer of IntraBio Inc.

He was appointed as Professor of Neurology, Pediatrics and Medical Genetics at Mayo Clinic from 2009 through 2024. He became Emeritus Professor in January, 2025. Dr Patterson served as Director of the Child Neurology Training Program at Mayo (2008-2016), and Chair of the Division of Child and Adolescent Neurology (2008-2017). He had previously served as Professor and Director of Pediatric Neurology and Director of the Child Neurology Training Program at Columbia University in New York (2001-2007).

Dr Patterson served as Editor for the Journal of Inherited Metabolic Disease and JIMD Reports, Editor-in Chief of the Journal of Child Neurology and Section Editor (Pediatric Neurology) for Up-To-Date through his retirement from Mayo Clinic in 2024. He has previously served on the editorial board of Neurology and the oversight committee for Annals of Neurology.

His research and practice have focused on rare diseases in children, including inherited metabolic disorders in general, with special interests in Niemann-Pick disease, type C (NPC), other lysosomal diseases, and congenital disorders of glycosylation, areas in which he has published more than 250 peer-reviewed papers and book chapters.

Dr Patterson was born and educated in Australia. He graduated with first class honors in medicine from the University of Queensland in 1981 and trained in neurology and child neurology at the University of Queensland (1982-1988) in child neurology at Mayo Clinic (1988-1990) and neurometabolic disease at the Developmental and Metabolic Neurology Branch, NINDS/NIH (1990-1992). Dr Patterson is a fellow of the Royal Australasian College of Physicians and is certified by the ABPN in Neurology with special qualification in Child Neurology, and in Neurodevelopmental disabilities.